Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

Wheezing: full-pipeline trial registry

3 of 8 indexed Wheezing trials are currently recruiting.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Wheezing: 8 US clinical trials tracked, 3 recruiting.

Wheezing is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Oregon Health and Science University, running 2 of these trials.

Enrollment posture brief

Registry condition wheezing

OPEN 3 | RECR 38% | LATE 1 | EARLY 1 | RANK #2176 | SPON 2

Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)

Activity, Motor75%Achalasia50%Wheezing (this)38%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Wheezing

Wheezing lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Wheezing on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Wheezing is recruiting below its size-band peers.

    3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Wheezing research.

    Oregon Health and Science University accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Wheezing enrolment sits around 192 participants.

    Median target enrolment is 192 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Wheezing research leans observational.

    2 interventional and 6 observational studies make up this index (25% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Wheezing records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

No current intervention Other
1 trials
No active intervention in this protocol (previously randomized to Placebo) Other
1 trials
No active intervention in this protocol (previously randomized to Vitamin C) Dietary supplement
1 trials
matching placebo Drug
1 trials
Soy isoflavone Drug
1 trials
Dupilumab Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Wheezing trials. A trial with sites in several states counts in each.

Oregon 2 trials
North Carolina 2 trials
Kentucky 2 trials
Indiana 2 trials
Illinois 2 trials
Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Wheezing page

8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Wheezing condition card totals 8 registered trials; most-linked intervention No current intervention; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.